Abstract
We present clinical data, HLA genotyping and serological profiling on a large cohort of JDM patients and a carefully characterized subset of patients with JDM-SSc overlap. The results confirm known HLA associations and extend the knowledge by stratification of data in serological and clinical subgroups. In the future, a combination of serological and genetic typing may allow for better prediction of clinical course and disease subtype in JDM.
Original language | English |
---|---|
Pages (from-to) | 1786-1791 |
Number of pages | 6 |
Journal | Rheumatology |
Volume | 46 |
Issue number | 12 |
DOIs | |
Publication status | Published - 2007 |